Health inequalities, the financial crisis, and infectious disease in Europe
This report summarises the importance of addressing health inequalities by identifying key areas for attention from health professionals and policy makers. Presenting key findings from studies on the subject, it makes the case that socio-economic determinants can have a substantial impact on infectious disease control in Europe.
This report addresses key emerging issues related to health inequalities and infectious disease control in the EU with potential links to the economic downturn.
The financial crisis continues to influence many of the key social determinants of health in Europe, both through changes to living conditions and to public spending. Health inequalities are present within the EU/EEA and recent evidence suggests that the financial crisis may have widened inequalities in many EU Member States as well as possibly adversely impacting members of vulnerable groups.
Infectious diseases, like other health issues, can be seen as both an indicator and product of the structure of society. Individuals are rarely subject to one key health determinant but often multiple determinants interact to affect health outcomes such as; wealth and distribution, unemployment, education, and the living environment and urbanisation. The report highlights the importance of addressing health inequalities by identifying key areas for attention from health professionals and policy makers.
In conjunction with the report, ECDC is hosting a meeting in Stockholm which will discuss to what extent health inequalities are important for infectious disease prevention and control, and share experiences and best practices on how negative effects can be mitigated. It will be attended by experts from most Members States as well as international experts on the subject.
ECDC Evidence Brief: Pre-exposure prophylaxis for HIV prevention in Europe and Central Asia
28 Nov 2019 - This evidence brief summarises key issues and priorities for action in Europe and Central Asia on PrEP. It is largely based on data collected in 2018 and 2019 by the European Centre for Disease Prevention and Control (ECDC) to monitor implementation of the 2004 Dublin Declaration. The monitoring questionnaire was disseminated to the 53 countries that are part of the WHO European Region, plus Kosovo and Liechtenstein via an online survey.
HIV testing, Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2018 progress report
27 Nov 2019 - This report presents the situation of HIV testing in Europe and Central Asia. It summarises data on implementation of national guidelines that shape HIV testing policies, the provision and uptake of HIV testing services in general and among key populations, and efforts being made to widen engagement with HIV testing and reduce late diagnosis.
External quality assessment of laboratory performance – European Antimicrobial Resistance Surveillance Network (EARS-Net), 2018
22 Nov 2019 - This report provides an analysis of the external quality assessment (EQA) performance with antimicrobial susceptibility testing (AST) of laboratories participating in the European Antimicrobial Resistance Surveillance Network in 2018. A total of 860 laboratories (1 – 114 per country) from 30 EU/EEA countries participated in the EQA exercise. Six bacterial strains were used: Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, Enterococcus faecium and Streptococcus pneumoniae.